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Abstract 
Possible regulation of fast Na + channels by tyrosine kinase was examined in a human uterine smooth muscle cell line, using 
whole-cell voltage clamp (at a holding potential of - 90 mV). Bath application of genistein, an inhibitor of tyrosine kinase, decreased the 
fast Na + current (IN,f)) dose-dependently. The maximal inhibition of INane) was 98%, and the concentration for half-maximal inhibition 
(ICs0) was 9/xM. The effect of genistein was rapidly reversible. Daidzein, an inactive analog of genistein, had a similar inhibitor effect 
on INalf)' These results uggest that the fast Na ÷ channels in uterine sarcoma cells may be directly blocked by genistein and daidzein, i.e., 
their effect may be independent of tyrosine kinase inhibition. 
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Voltage-dependent fast Na + channels may play a key 
role in excitability and propagation of uterine smooth 
muscle during labor [ 1 ]. Protein phosphorylation (on serine 
and/or threonine groups) is a major regulatory process for 
the modulation of ion channels such an L-type Ca 2+ 
channels in neuronal cells, myocardial cells, and vascular 
smooth muscle cells [2,3]. In uterine smooth muscle cells, 
cAMP and cGMP (and their respective protein kinases) do 
not modulate the L-type Ca 2+ current  (/Ca(L)) [1], whereas 
protein kinase C (PKC) increases /Ca(L) [4]. There are also 
some reports about the modulation of the fast Na + chan- 
nels by cAMP [5] or PKC [6]. However, in myometrial 
cells, cAMP, cGMP, and PKC do not appear to modulate 
the fast Na + current (1Na(f)) (Kusaka, M. and Sperelakis, 
N., unpublished ata). To examine the possible modulation 
of Na + channels by tyrosine-specific protein kinase in 
uterine cells, we examined the effect of genistein, an 
inhibitor of tyrosine protein kinase (TPK). 
Tyrosine kinase has been shown to be correlated with 
the signal transduction for several growth factors, such as 
epidermal growth factor (EGF) [7], fibroblast growth factor 
(FGF) [8], platelet-derived growth factor (PDGF) [9], and 
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for insulin [10]. In neuronal cells, these growth factors 
were reported to cause expression of fast Na ÷ channels in 
neurons [11], basic FGF to increase /Ca(L) [12,13]. TPK 
inhibitors, such as genistein, were reported to block the 
Ca 2÷ current in vascular smooth muscle cells [14], and to 
activate a non-selective cation channel [15]. However, no 
reports have been published about the regulation of the fast 
Na ÷ current (INa(f)) by TPK. 
In this study, we investigated the possible modulation 
of the fast Na-- channels by TPK in human uterine 
leiomyosarcoma cells by studying the effect of TPK in- 
hibitors using the whole-cell patch clamp. The leiomyosar- 
coma cell line (SK-UT-1B), derived from human uterine 
myometrial cells, was used for the present study because it 
is a good model for the uterine smooth muscle cells of 
late-pregnant rats. It was demonstrated that the rat myome- 
trial cells gain fast Na + channels during late pregnancy, 
which may play an important role in normal abor [16,17]. 
We discovered that the leiomyosarcoma cell also exhibits 
INa(f), under the control of one or more factors in serum 
[18]. In addition, INa(f) was almost 10-fold greater in 
density in the leiomyosarcoma cell, compared to the preg- 
nant rat myometrial cell. We found that INa(f) is inhibited 
by both the TPK inhibitor, genistein, and its inactive 
analog, daidzein. Thus, endogenous TPK activity may not 
be involved in the regulation of Na ÷ channel activity in 
myometrial cells. 
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The human leiomyosarcoma cell line (SK-UT-1B) was 
obtained from American Type Culture Collection (Rock- 
ville, MD). The cells were kept frozen in small aliquots at 
-80°C. To start cell growth, some aliquots were trans- 
ferred to culture flasks (25 cm 2 bottom), and the cells were 
grown in Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 5% fetal bovine serum (FBS) (JRH 
Bioscience, Lenexa, KS), 100 U/ml penicillin G, and 100 
/xg/ml streptomycin (Gibco Laboratories, Grand Island, 
NY). The cell cultures were maintained at 37°C in a 
humidified atmosphere of 5% CO 2 and 95% air, and 
grown until confluency. The cells were passaged every two 
weeks. For passage, confluent monolayers were dissoci- 
ated from the flasks using phosphate-buffered saline con- 
taining the proteolytic enzyme, dispase (0.5 mg/ml) 
(Boehringer Mannheim, Indianapolis, IN). The culture 
medium was changed every 2-3 days for cell 'feeding'. 
For patch-clamp experiments, cells were plated on cover- 
slips and incubated in medium for 24-72 h. 
Whole-cell voltage clamp recording was carried out 
with a suction pipette and a patch clamp amplifier 
(Axopatch-1 D, Axon Instruments, Foster City, USA) using 
standard techniques. The patch electrodes (2-5 M ~)  were 
made from borosilicate glass capillary tubing (World Pre- 
cision Instruments, USA). The cell suspension was placed 
into a small chamber (0.2 ml) on the stage of an inverted 
microscope (TMD-Diaphoto, Nikon, Tokyo, Japan). To 
isolate IN~. ), the pipette was filled with high Cs + solution 
of the following composition (in raM): 110 CsOH, 20 
CsC1, 110 glutamic acid, 5 MgC12, 10 Hepes, 5 Na2ATP, 
10 EGTA (pH 7,2). The bath solution contained (in raM): 
140 NaC1, 2 NiC12, 10 glucose, 10 Hepes, 3 4-aminopyri- 
dine (pH 7.35). 
Series resistance was partly (ca. 80%) compensated 
electrically. Leak current and residual capacitive current 
were subtracted using the P /4  protocol. Current and volt- 
age signals were filtered at 2 kHz and digitized by an A /D  
converter (TL-1, Axon Instruments), and analyzed on an 
IBM-AT personal computer using the pCLAMP software 
(Axon Instruments). The membrane capacitance was deter- 
mined from the current amplitude licited in response to a 
hyperpolarizing voltage ramp pulse of 0.2 V /s  from a 
holding potential (HP) of 0 mV to avoid interference by 
any time-dependent ionic currents. All experiments were 
carried out at room temperature (22-24°C). 
Genistein and daidzein were obtained from Cal- 
biochem-Novabiochem Corp. (San Diego, CA, USA). 
These agents were dissolved in dimethylsulfoxide (DMSO) 
for a stock solution, and aliquots frozen until use. The final 
maximal concentration of DMSO (0.1%) had no effect on 
INa(f)" 
Data are presented as means _+ S.E. Theoretical curves 
were fitted to the data with the least-squares method. 
The mean membrane capacitance of the sarcoma cells 
was 37.1 + 2.4 pF (n = 34), and it was not affected by 
application of genistein or daidzein. Unless stated other- 
Table 1 
Effects of genistein and daidzein on ]Na(f) in uterine leiomyosarcoma 
cells (SK-UT-1 B) 
Peak /Nail} 
(% of control) 
Genistein 100 p~M 8.3_+ 1.4 (6) 
Daidzein 100 /xM 19.0_+ 3.6 (5) 
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Fig. 1. Inhibition of /Na(f) by genistein (100 /xM) in a human uterine 
leiomyosarcoma cell. The effect reached a stable level within 2 min after 
bath application of genistein, and was rapidly reversed by washout. 
Currents were elicited from a HP of -90  mV to a step potential of 0 mV 
every 20 s. (Inset) Superimposed current traces howing the INTO. ~ recorded 
before (a) and 4 rain after (b) application of genistein, and after washout 
(c). 
wise, the 1h~f) was elicited by 20 ms depolarizing step 
pulses to 0 mV from a HP of -90  mV every 20 s. The 
study of the effect of genistein was started when INa~f )
became stabilized after breaking into the cell. The current 
was completely inhibited by tetrodotoxin (TTX) (data not 
shown), and the kinetic properties including inactivation 
time-course and current-voltage r lationship were consis- 
tent with those of INa(f) we reported previously for uterine 
smooth muscle cells [16,17]. 
Bath application of genistein (100 /xM) reduced ls,~f )
by 91.7 _+ 1.4% (n = 6) (Table 1). Fig. 1 shows the time- 
course of the effect of genistein on peak current amplitude 
in one representative experiment. The decrease in Iya0) 
started within 1 rain after application of genistein, and 
reached a stable level within 2 min. The effect of genistein 
on INa0. ) was almost completely reversed by washout. 
Superimposed current races before (a) and 4 rain after (b) 
genistein application, and after washout (c) are given in the 
inset. The current-voltage r lationship for peak lya~f) was 
not significantly shifted by genistein (data not shown); 
there was no obvious change in voltages for threshold or 
peak current. 
Fig. 2 shows the dose-response curve for the inhibitory 
effect of genistein. Peak INa(f ) amplitude in the presence of 
genistein was plotted against he various concentrations of 
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Fig. 2. The dose-response r lationship for genistein inhibition of INa(f ~ in 
human uterine leiomyosarcoma cells. Peak /Na( f )  amplitude was measured 
before and 4 min after application of various concentrations of genistein 
in the bath. Pulse protocol was the same as in Fig. 1. Numbers in 
parentheses indicate the number of cells for each data points. Points 
plotted are the mean _+ S.E. The IC50 value was 9.0 #M. 
the drug as a percent of control. Data points were fitted to 
the Hill equation: l~,i~t~iJl~o,u.ol (%) = Emax/[1 + 
([genistein]/1Cs0) 'm] + (100-  E .... ), where Ema ~ is the 
maximum inhibitory effect, n H is the Hill coefficient, IC50 
is the concentration of the drug causing 50% of the 
maximal inhibitory effect. The n n value was 1.1, and the 
IC50 value was 9.0 p,M. The maximum inhibitory effect 
was calculated to be 98.0%. 
In order to examine whether the effect of genistein on 
IN~(r ) was mediated by TPK, experiments were performed 
using daidzein, which has a similar structure to genistein, 
but has no inhibitory effect on TPK [19]. Bath application 
of 100 /xM daidzein decreased IN~(t) almost as much as 
genistein (Fig. 3). The mean percent decrease of the peak 
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Fig. 3. Effect of daidzein, an inactive genistein analog, on /Na(f} in a 
leiomyosarcoma cell. Bath application of daidzein (100 /xM) produced 
marked inhibition of the current. The experimental protocol was the same 
as in Fig. 1. (Inset) Superimposed current traces recorded during the 
control period (a), in the presence of daidzein (b), and after washout (c). 
/Na(f) produced by daidzein was 81.0 + 3.6% (n = 5) (Ta- 
ble 1). Two other concentrations of daidzein were tested 
and the percent decrease in the peak current was 6.0 +_ 1.8% 
(n = 3) at 1 #M and 40.6_+ 6.0% (n = 3) at 10 /xM. 
The time course of recovery of IN~ m upon washout of 
the drugs was sometimes very fast (e.g,, within 2 min) and 
complete (e.g., Fig. 1), whereas in some experiments it
was slower and incomplete (e.g., Fig. 3). In this respect. 
there was no difference between the two drugs; i.e., the 
recovery was variable with both genistein and daidzein. 
In the present study, we found that a selective TPK 
inhibitor, genistein, inhibits INa/v ) dose-dependently in hu- 
man uterine leiomyosarcoma cells. The maximal inhibition 
was nearly 100%, and the IC50 value was 9 / ,M.  The onset 
of the inhibition of IN~,. ) produced by genistein was fast 
(within a few minutes), and the effect could be quickly 
washed out. The inactive genistein analog, daidzein, also 
produced a similar decrease of the current. These results 
suggest that INtuit. t inhibition produced by genistein may 
not be mediated by inhibition of endogenous TPK activity, 
but rather may be a direct effect on the ion channel. We 
believe this to be true, although the concentration range of 
genistein that affected IN,it. ) in this study (IC50 = 9/xM) is 
comparable to that needed for the inhibition of tyrosine 
kinases [19]. The Hill coefficient of 1.1 (see Fig. 2) 
suggests that one drug molecule is sufficient to block one 
ion channel. 
A direct blocking action of genistein on the Na + chan- 
nels is likely. Genistein and daidzein had similar potent 
inhibitory effects on /Nail)' The IC50 values of these agents 
for the inhibition of EGF receptor kinase were reported to 
be 2.6 /xM and > 370 /,M, respectively [19]. Therefore, 
at the concentrations we used in this study (1-100 /xM), 
daidzein should not affect TPK. Consistent with our find- 
ings, both active and inactive tyrphostin derivatives were 
reported to inhibit lc~{c) in vascular smooth muscle cells 
[14]. This provides evidence for a direct action of these 
agents on the ion channel proteins. In addition, the rapid 
onset of the effect of genistein and the rapid offset (washout 
recovery) may suggest a direct action on the outer surface 
of the channel. Since the maximum degree of inhibition of 
/Nail) was  almost 100% (Fig. 2), this is consistent with a 
site of action directly on the channel protein. 
In contrast to the present results, we found that, in 
late-pregnant rat myometrial cells, genistein inhibited Ica~c) 
only to about 50% of control, and daidzein had no effect 
[20]. We concluded, therefore, that the genistein inhibition 
of the lc~{c) was mediated by inhibition of the TPK 
activity, and that there was a tonic stimulation of the Ca 2~ 
channels by phosphorylation with TPK. In contrast, the 
present experiments suggest hat the fast Na + channels are 
not likely to be modulated by phosphorylation with TPK, 
and that the drug acts as a direct blocker of the Na + 
channels. 
In summary, genistein inhibits Ixal~ ) in human uterine 
leiomyosarcoma cells. This effect may not be mediated by 
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inhibition of TPK, but may be a direct action on the Na ÷ 
channels. The present results showing that genistein in- 
hibits /Na(f) at a concentration similar to that required for 
inhibition of TPK activity, should serve as a warning that 
such drugs may exert more than one action. Therefore, 
investigators making use of such enzyme inhibitors must 
be made aware and exercise caution accordingly. 
This work was supported by grant from the National 
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